Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview

QR Code

Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview

Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for clinical use only 15 years ago. Since then, 33 more kinase inhibitor drugs have received regulatory approval for the treatment...

Full description

Bibliographic Details
Main Author:	Fischer, Peter M.
Format:	Article
Published:	Wiley 2017
Subjects:	Cancer Oncology Kinase inhibitor Experimental drug Drug design Clinical trials
Online Access:	https://eprints.nottingham.ac.uk/37903/

Similar Items

Discovery of highly potent and selective phosphatidylinositol 3-kinase-δ inhibitors for the treatment of blood cancers and autoimmune diseases
by: Buzrieda, Anas
Published: (2021)

Systematic overview of clinical trials of antiarrhythmic drugs
by: Shilbayeh, Sirin
Published: (1998)

An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)

Factors affecting recruitment to breast cancer clinical trials: an examination of the British Association of Surgical Oncology II trial and the International Breast Cancer Intervention Study
by: Maslin-Prothero, Sian
Published: (2000)

Development of an EGFR-targeted Drug Delivery System for Glioblastoma
by: Zhao, Zi-Ruo
Published: (2023)

Evaluation of transcriptional cyclin dependent kinase inhibitors as potential cancer therapeutics
by: Liu, Xiangrui
Published: (2012)

Systematic review of safety in paediatric drug trials published in 2007
by: Nor Aripin, Khairun Nain Bin, et al.
Published: (2012)

Protein Kinase C-Delta C2 Domain Interactions in Breast Cancer
by: Khader, Rasha
Published: (2023)

Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021)

Alternative splicing and the inhibition of splicing kinases in Alzheimer’s Disease
by: Alalwany, Roaa
Published: (2021)

Real-time analysis of the binding of fluorescent VEGF₁₆₅a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes
by: Kilpatrick, Laura E., et al.
Published: (2017)

Development of existing and novel tyrosinase inhibitors for skin pigmentation: intradermal delivery, biological evaluation and mechanistic studies
by: Li, Zhiwei
Published: (2023)

Randomized factorial trial of esomeprazole and aspirin in Barrett’s oesophagus: the Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)

A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study
by: Clark, Richard E., et al.
Published: (2017)

How clinically relevant are treatment comparisons of topical calcineurin inhibitor trials for atopic eczema?
by: Wilkes, Sally R., et al.
Published: (2016)

Examining the importance of survivin phosphorylation at Threonine 5 through its relationship with the kinase, TBK1, and the substrate, c-Src
by: Lishak, Jamie
Published: (2019)

Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells.
by: Cao, Jia-ning, et al.
Published: (2010)

Synthesis and investigation of anti-tyrosinase and antioxidant activity of new halogenated xanthone derivatives
by: Baharuddin, Fatin Farhana
Published: (2023)

Investigating the relationship between Survivin and Tank-Binding Kinase 1 in cancer cells
by: Daly, Lauren
Published: (2021)

Roles & mechanisms of NANOG-mediated drug resistance in human colorectal cells
by: Shaheen, Sameerah
Published: (2017)

Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
by: Biabanikhankahdani, Roya
Published: (2017)

Yeast Glycogen Synthase Kinase-3 Pathway Inhibitors from an Organic Extract of Streptomyces sp.
by: Cheenpracha, Sarot, et al.
Published: (2009)

Creatine kinase and SLCO1B1 RS4363657 polymorphism in Malaysian dyslipidaemic patients prescribed with statin drugs
by: Meor Anuar Shuhaili, Meor Fairuz Rizal
Published: (2016)

CARP-1 functional mimetics: a novel class of small molecule inhibitors of cancer cell growth and metastasis
by: Ashour, Abdelkader Elbadawy Abbas
Published: (2019)

Design and synthesis of small molecule inhibitors of coagulation FXIIa
by: Chen, Xi
Published: (2018)

Analysis of adverse drug reactions related to drug-induced renal injury based on spontaneous adverse drug reactions reporting in Malaysia 2010 – 2014 / Nurulmaya Ahmad Sa'ad
by: Ahmad Sa'ad, Nurulmaya
Published: (2016)

Design, Synthesis and Biological Evaluation of Novel Inhibitors of InhA from Mycobacterium tuberculosis
by: Armstrong, Tom
Published: (2021)

Assessment of pharmacists, public and general retailers perspectives, awareness and knowledge of registered drugs and unregistered drugs in Klang Valley / Nur Wahida Zulkifli
by: Zulkifli, Nur Wahida
Published: (2018)

Silk Road: Ebay for drugs
by: Barratt, Monica
Published: (2012)

Factor of drug rejections and stigma toward drug consumers and drugs / Seema Shamira Muhammad Sani Surinder, Abdul Rauf Ridzuan and Rosilawati Sultan Mohideen
by: Muhammad Sani Surinder, Seema Shamira, et al.
Published: (2019)

Learning lessons from adverse drug reactions in children
by: Sammons, Helen, et al.
Published: (2016)

Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)

The suppression of illicit drugs through international law
by: Boister, Neil
Published: (1998)

Effect of combination therapy of ruthenium polypyridyl complex, [Ru(dppz)2(PIP)]2+ and parp inhibitors against several cancer cell lines
by: Yusoh, Nur Aininie
Published: (2020)

Quantifying patient benefit using semi-Markov multi-state models
by: Jameel, A. Haris
Published: (2024)

Evaluation of drug related problems in hospitalized acute coronary syndrome patients / Kuapih @ Florina Kimjun
by: Kimjun, Kuapih @ Florina
Published: (2014)

Drug utilization review among geriatric patients at primary care setting / Saidatul Sheeda Ahmad Shukri
by: Ahmad Shukri, Saidatul Sheeda
Published: (2015)

An observational feasibility study of a new anaesthesia drug storage tray
by: Almghairbi, Dalal S., et al.
Published: (2018)

Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
by: Sarwar, Martuza, et al.
Published: (2016)

Use of SRPK1 inhibitors for the treatment of Diabetic Retinopathy
by: Malhi, Naseeb
Published: (2021)